补肾祛瘀方辅助治疗良性前列腺增生PVP 术后患者临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R697.3

基金项目:


Clinical Study on Bushen Quyu Formula Assisting Treatment for Patients After PVP for Benign Prostatic Hyperplasia
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察补肾祛瘀方辅助治疗良性前列腺增生(BPH) 经尿道选择性绿激光前列腺汽化 术(PVP) 术后患者的临床疗效及其对排尿功能、性激素水平的影响。方法:将120 例BPH 行PVP 术后患者 采用抽签法分为西药组和综合组各60 例。西药组术后给予常规干预及盐酸坦洛新缓释片治疗,综合组在西药 组基础上联合补肾祛瘀方治疗。比较2 组临床疗效、症状改善情况、排尿功能、性激素水平及不良反应。结 果:治疗前,2 组国际前列腺症状评分(IPSS)、膀胱过度活动症评分(OABSS) 比较,差异无统计学意 义(P>0.05);治疗后,2 组IPSS、OABSS 评分均降低(P<0.05),且综合组低于西药组(P<0.05)。综合组 临床总有效率95.00%, 高于西药组81.67% (P<0.05)。治疗前, 2 组最大尿流率(Qmax)、残余尿 量(PVR)、日间及夜间排尿次数、尿急次数比较,差异无统计学意义(P>0.05);治疗后,2 组PVR、日间 排尿次数、夜间排尿次数、尿急次数均减少(P<0.05),Qmax 均增大(P<0.05),且综合组PVR、日间排尿 次数、夜间排尿次数、尿急次数少于西药组(P<0.05),Qmax 大于西药组(P<0.05)。治疗前,2 组血清睾 酮(T)、催乳素(PRL)、雌二醇(E2)、促黄体生成素(LH) 水平比较,差异无统计学意义(P>0.05);治疗 后,2 组血清T、PRL 水平升高(P<0.05),E2、LH 水平降低(P<0.05),且综合组血清T、PRL 水平高于西 药组(P<0.05),E2、LH 水平低于西药组(P<0.05)。2 组不良反应发生率比较,差异无统计学意义(P> 0.05)。结论:补肾祛瘀方治疗BPH 行PVP 术后患者,可通过减轻尿道压力,改善排尿功能,改善症状,调控 性激素水平,降低尿道刺激、胃肠道反应等不良反应的发生,提高临床疗效。

    Abstract:

    Abstract: Objective: To observe the clinical effect of Bushen Quyu Formula assisting treatment for patients after photoselective vaporization of the prostate (PVP) for benign prostatic hyperplasia (BPH) and its effect on urination function and levels of sex hormones. Methods:A total of 120 cases of patients with BPH after PVP were divided into the western medicine group and the comprehensive group according to the method of random sampling,with 60 cases in each group. After operation,the western medicine group was given routine intervention and Tamsulosin Hydrochloride Sustained- Release Tablets , and the comprehensive group was additionally treated with Bushen Quyu Formula based on the treatment of the western medicine group. The clinical effects,improvement of symptoms,urination function,levels of sex hormones and adverse reactions were compared between the two groups. Results: Before treatment, there was no significant difference being found in the comparison of scores of International Prostate Symptom Score (IPSS) and Overactive Bladder Symptom Score (OABSS) between the two groups (P> 0.05). After treatment,the scores of IPSS and OABSS in the two groups were decreased when compared with those before treatment (P<0.05),and the scores in the comprehensive group were lower than those in the western medicine group (P<0.05). The total clinical effective rate was 95.00% in the comprehensive group,higher than that of 81.67% in the western medicine group (P<0.05). Before treatment,there was no significant difference being found in the comparison of maximal urinary flow rate (Qmax), post- void residual (PVR), frequency of urination during daytime and at night, and number of urgent urination between the two groups (P>0.05). After treatment,the PVR,frequency of urination during daytime and at night, and number of urgent urination were decreased in the two groups (P<0.05), and the Qmax was increased (P<0.05);the PVR,frequency of urination during daytime and at night,and number of urgent urination in the comprehensive group were less than those in the western medicine group (P<0.05),and Qmax was larger than that in the western medicine group (P<0.05). Before treatment, there was no significant difference being found in the comparison of the levels of testosterone (T), prolactin (PRL), estradiol (E2) and luteinizing hormone (LH) in serum between the two groups (P>0.05). After treatment,the levels of T and PRL in serum were increased (P<0.05),and levels of E2 and LH were decreased (P<0.05); the levels of T and PRL in serum in the comprehensive group were higher than those in the western medicine group (P<0.05),and levels of E2 and LH were lower than those in the western medicine group (P<0.05). There was no significant difference being found in the comparison of the incidence of adverse reactions between the two groups (P>0.05). Conclusion: Bushen Quyu Formula assisting treatment for patients after PVP for BPH can improve the clinical effect by reducing urethral pressure,improving urination function, regulating improvement of symptoms and levels of sex hormones, and decreasing the occurrence of urethral stimulation,gastrointestinal reactions and other adverse reactions.

    参考文献
    相似文献
    引证文献
引用本文

李景远,周理.补肾祛瘀方辅助治疗良性前列腺增生PVP 术后患者临床研究[J].新中医,2023,55(3):103-107

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2023-02-17
  • 出版日期:
文章二维码